174900 — AbClon Balance Sheet
0.000.00%
- KR₩358bn
- KR₩352bn
- KR₩2bn
Annual balance sheet for AbClon, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS/A | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | — | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 19,549 | 10,266 | 24,140 | 17,498 | 21,863 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,449 | 1,092 | 576 | 232 | 704 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 21,456 | 11,888 | 24,956 | 19,339 | 23,224 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17,891 | 17,063 | 26,887 | 25,205 | 24,118 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 40,130 | 29,828 | 54,021 | 45,436 | 48,183 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,546 | 10,043 | 8,580 | 17,618 | 18,107 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 10,800 | 10,469 | 17,284 | 18,208 | 18,777 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 29,329 | 19,359 | 36,737 | 27,227 | 29,406 |
| Total Liabilities & Shareholders' Equity | 40,130 | 29,828 | 54,021 | 45,436 | 48,183 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |